Abstract:Abstract Background Before starting gonadotoxic therapies, cryopreservation of mature sperm has been proposed worldwide as a method for male fertility preservation and for enabling the conception of a healthy baby with assisted reproductive technology (ART); however, these technologies are not feasible for prepubertal boys and men with spermatogenic failure. Transplantation of mesenchymal stem cells has exhibited successful therapeutic benefits in restoring spermatogenesis via gonadal graft angiogenesis, transplanted cell clonogenesis, and disordered somatic compartment recovery. This study aimed to elucidate the fertility protective effects and the underlying mechanisms of human amnion mesenchymal stem cells (hAMSCs) against busulfan-induced testis toxicity. Methods An in vivo busulfan-induced testis toxicity mouse model and an in vitro busulfan-administered mouse Sertoli cell line were employed to evaluate the efficacy and mechanisms of hAMSC transplantation on male fertility preservation. The process of spermatogenesis was evaluated histologically, and the percentage of seminiferous tubules with vacuoles was evaluated by HE staining. Semen parameters were calculated by computer-assisted semen analysis. ELISA was employed to test the testosterone concentration and the levels of oxidative- and antioxidative-associated substances LDH, MDA, GR, SOD, GPx, and CAT. The rates of proliferation (Ki67), apoptosis (Annexin V), and ROS were measured by FACS. The fluorescence intensity of a marker of apoptosis (TUNEL) and a meiosis gene in spermatogenesis (SCP3) were detected by immunofluorescence assay. The expression of mRNA in germ cell-specific (GCS) genes (Dazl, Ddx4, and Miwi) and meiosis genes (Scp3, Cyclin A1, and Stra8) was tested by qPCR. The expression of antiapoptotic proteins (SURVIVIN and BCL2), apoptotic proteins (CASPASE3 and CASPASE9), GCS proteins (Dazl, Ddx4, and Miwi), and meiosis proteins (Scp3, Cyclin A1, and Stra8) was tested by western blotting. Results hAMSC transplantation following disruption by busulfan-induced testis toxicity restored spermatogenesis, elevating testosterone levels and enhancing testicular weight, size, and semen parameters in vivo. In addition, hAMSCs clearly ameliorated cell apoptosis, enhanced cell proliferation, repressed oxidative damage, and augmented oxidative defense in vivo and in vitro. Moreover, hAMSCs distinctly increased the expression of the GCS genes Dazl, Ddx4, and Miwi and the meiosis genes Scp3, Cyclin A1, and Stra8 in vivo. Conclusions hAMSCs might represent a promising tool for the use in regenerative medicine, as these cells can restore spermatogenesis in a busulfan-induced testis toxicity mouse model and facilitate activity in a busulfan-administered mouse Sertoli cell line by resisting apoptosis and oxidative stress.

Generation of Haploid Spermatids with Fertilization and Development Capacity from Human Spermatogonial Stem Cells of Cryptorchid Patients.

Efficient Generation of Functional Haploid Spermatids from Human Germline Stem Cells by Three-Dimensional-induced System

Activated Dormant Stem Cells Recover Spermatogenesis in Chemoradiotherapy-Induced Infertility

Cellular Therapy via Spermatogonial Stem Cells for Treating Impaired Spermatogenesis, Non-Obstructive Azoospermia

Generation Of Mice By Transplantation Of An Adult Spermatogonial Cell Line After Cryopreservation

Spermatogonial Stem Cells for In Vitro Spermatogenesis and In Vivo Restoration of Fertility

Generation of male differentiated germ cells from various types of stem cells.

Differentiation of Spermatogonial Stem Cell-Like Cells from Murine Testicular Tissue into Haploid Male Germ Cells in Vitro.

Retinoic Acid Combined with Spermatogonial Stem Cell Conditions Facilitate the Generation of Mouse Germ-Like Cells

Human amnion mesenchymal stem cells restore spermatogenesis in mice with busulfan-induced testis toxicity by inhibiting apoptosis and oxidative stress

Direct Reprogramming of Human Sertoli Cells into Male Germline Stem Cells with the Self-Renewal and Differentiation Potentials Via Overexpressing DAZL/DAZ2/BOULE Genes

Expansion and Long-Term Culture of Human Spermatogonial Stem Cells Via the Activation of SMAD3 and AKT Pathways

Derivation and propagation of spermatogonial stem cells from human pluripotent cells

Generation of spermatogonia from pluripotent stem cells in humans and non-human primates

Decoding the pathogenesis of spermatogenic failure in cryptorchidism through single-cell transcriptomic profiling

Generation of Histocompatible Androgenetic Embryonic Stem Cells Using Spermatogenic Cells.

Identification and Manipulation of Spermatogonial Stem Cells with the Aim of Inducing Spermatogenesis in Vitro

Molecular Mechanisms of Proliferation and Differentiation of Spermatogonial Stem Cells

In Vitro Production of Haploid Germ Cells from Murine Spermatogonial Stem Cells Using a Two-Dimensional Cell Culture System.

In Vitro Generation of Haploid Germ Cells from Human XY and XXY Immature Testes in a 3D Organoid System

Xenotransplantation of Human Spermatogonia into Various Mouse Recipient Models